Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 13, 2016
Fluoxetine disrupts motivation and GABAergic signaling in adolescent female hamstersJohn L Shannonhouse, Dustin W DuBois, Annette S Fincher, et al.Neuroscience|August 19, 2017
Loss of sestrin 2 potentiates the early onset of age-related sensory cell degeneration in the cochleaCelia Zhang, Wei Sun, Ji Li, et al.Psychopharmacology|January 1, 1980
Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxideR A Vogel, G D Frye, J H Wilson, et al.Cancer|January 1, 1989
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinomaG N Hortobagyi, D Frye, A U Buzdar, et al.American Journal of Clinical Oncology|January 1, 1990
Pirarubicin in combination chemotherapy for metastatic breast cancerG N Hortobagyi, R L Theriault, D Frye, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancerA U Buzdar, G N Hortobagyi, D Frye, et al.Cancer|January 9, 2001
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapyE Rivera, F A Holmes, D Frye, et al.Physical Review Letters|January 7, 2021
Observation of Efimov Universality across a Nonuniversal Feshbach Resonance in ^{39}KXin Xie, Michael J Van de Graaff, Roman Chapurin, et al.Cancer|May 17, 2000
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapyP M Hoff, V Valero, A U Buzdar, et al.Southern Medical Journal|November 1, 1991
Dynamic stereotactic radiosurgery using a linear acceleratorC Worthington, J M Jenrette, J O Fenn, et al.Pageof 16